microRNA 3920 (MIR3920)

microRNA 3920 (MIR3920, hsa-mir-3920) is a short, non-coding RNA molecule (miRNA) belonging to the microRNA family and encoded in the human genome. Like other microRNAs, its biological role is to mediate post-transcriptional gene regulation, typically by binding complementary sequences in target messenger RNAs (mRNAs), resulting in gene silencing through mRNA degradation or translational inhibition. microRNA 3920 itself is not a receptor, enzyme, transporter, or classical drug target, but may have roles in cell-specific gene regulatory networks. However, specific functions or disease associations for microRNA 3920 have not been characterized in the currently available literature. There are no known therapeutic drugs directly targeting microRNA 3920, nor has it been established as a clinical biomarker or associated with adverse safety concerns. Key context: microRNA 3920 belongs to the microRNA class of non-coding RNAs, defined by their size (about 20-24 nt) and gene-silencing function. MicroRNAs act as post-transcriptional regulators, commonly binding to 3’ untranslated regions (UTRs) of target mRNAs and inhibiting protein production via mRNA degradation or translational repression. MIR3920 is not found in curated lists of differentially expressed or functionally important microRNAs in diseases such as cancer, and no validated disease roles, drug interactions, or uses as a biomarker have been reported for this gene specifically. There is no indication from current databases or gene records that MIR3920 is misspelled or incorrect as a gene target, but lack of functional characterization means its specific biological and clinical relevance remains unclear.

Other names

hsa-mir-3920MIR3920